Skip to main content
Equibles

BARCLAYS PLC

Position in VRCA — Verrica Pharmaceuticals Inc.

CIK 312069 LONDON, X0
Back to VRCA Full portfolio

Position in VRCA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$391
+$383 QoQ
Shares Held
64
+6300.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 43 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRCA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. VRCA ranks #397 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in VRCA

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $391 64
2025-12-31 $8 1
2025-09-30 $4 1
2025-06-30 $8 16
2025-03-31 $19,617 44,383
2024-12-31 $21,003 30,005
2024-09-30 $45,444 31,341
2024-06-30 $45,278 6,211
2024-03-31 $86,396 14,594
2023-12-31 $209,644 28,640
2023-09-30 $14,110 3,632
2023-06-30 $24,072 4,172
2023-03-31 $109,993 16,922
2022-03-31 $17,233 2,125
2021-12-31 $145,607 15,896
2021-09-30 $66,900 5,352
2021-06-30 $19,289 1,707
2021-03-31 $157,544 10,399
2020-12-31 $46,212 4,015
2020-09-30 $44,636 5,767
2020-06-30 $75,991 6,902
2020-03-31 $46,714 4,274